ACIP Recommendations for Use of Seasonal Influenza Vaccines

The Aug. 7, 2015 issue of the CDC's Morbidity and Mortality Weekly Report (MMWR) provides a report that updates the 2014 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines. Updated information for the 2015-16 season includes:

- Antigenic composition of U.S. seasonal influenza vaccines

- Information on influenza vaccine products expected to be available for the 2015-16 season

- An updated algorithm for determining the appropriate number of doses for children aged 6 months through 8 years

- Recommendations for the use of live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) when either is available, including removal of the 2014-15 preferential recommendation for LAIV for healthy children aged 2 through 8 years.

To read further from the MMWR report, CLICK HERE.

Reference: Grohskopf LA, Sokolow LZ,  Olsen SJ,  Bresee JS, Broder KR and Karron RA. Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza Season. MMWR. Aug. 7, 2015; 64(30);818-825